Literature DB >> 11739276

Inducible activation of c-Myc in adult myocardium in vivo provokes cardiac myocyte hypertrophy and reactivation of DNA synthesis.

G Xiao1, S Mao, G Baumgarten, J Serrano, M C Jordan, K P Roos, M C Fishbein, W R MacLellan.   

Abstract

c-Myc, a protooncogene, mediates both proliferative and cellular growth in many cell types. Although not expressed in the adult heart under normal physiological conditions, Myc expression is rapidly upregulated in response to hypertrophic stimuli. Although Myc is capable of sustaining hyperplastic growth in fetal myocytes, the effects of its re-expression in adult postmitotic myocardium and its role in mediating cardiac hypertrophy are unknown. To determine the effects of de novo Myc activity in adult postmitotic myocardium in vivo, we created a novel transgenic model in which Myc is expressed and inducibly activated specifically in cardiac myocytes. Activation of Myc in adult myocardium was sufficient to reproduce the characteristic changes in myocyte size, protein synthesis, and cardiac-specific gene expression seen in cardiac hypertrophy. Despite the increased cardiac mass, left ventricular function remained normal. Activation of Myc also provoked cell cycle reentry in postmitotic myocytes, which led to increased nuclei per myocyte and DNA content per nuclei.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11739276     DOI: 10.1161/hh2401.100742

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  58 in total

1.  c-Myc is required for proper coronary vascular formation via cell- and gene-specific signaling.

Authors:  Colby A Souders; Stephanie L K Bowers; Indroneal Banerjee; John W Fuseler; Jennifer L Demieville; Troy A Baudino
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-08       Impact factor: 8.311

Review 2.  Cell cycle regulation to repair the infarcted myocardium.

Authors:  Joshua D Dowell; Loren J Field; Kishore B S Pasumarthi
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

Review 3.  Protein kinase cascades in the regulation of cardiac hypertrophy.

Authors:  Gerald W Dorn; Thomas Force
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

4.  p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes.

Authors:  Felix B Engel; Michael Schebesta; Mychelle T Duong; Gang Lu; Shuxun Ren; Jeffery B Madwed; Huiping Jiang; Yibin Wang; Mark T Keating
Journal:  Genes Dev       Date:  2005-05-03       Impact factor: 11.361

Review 5.  Cell-based approaches for cardiac repair.

Authors:  Michael Rubart; Loren J Field
Journal:  Ann N Y Acad Sci       Date:  2006-10       Impact factor: 5.691

Review 6.  Redirecting cardiac growth mechanisms for therapeutic regeneration.

Authors:  Ravi Karra; Kenneth D Poss
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

Review 7.  Cardiac myocyte cell cycle control in development, disease, and regeneration.

Authors:  Preeti Ahuja; Patima Sdek; W Robb MacLellan
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

8.  Overlapping roles of pocket proteins in the myocardium are unmasked by germ line deletion of p130 plus heart-specific deletion of Rb.

Authors:  W R MacLellan; A Garcia; H Oh; P Frenkel; M C Jordan; K P Roos; M D Schneider
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

9.  Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells.

Authors:  Clifford D L Folmes; Almudena Martinez-Fernandez; Randolph S Faustino; Satsuki Yamada; Carmen Perez-Terzic; Timothy J Nelson; Andre Terzic
Journal:  J Cardiovasc Transl Res       Date:  2012-12-18       Impact factor: 4.132

10.  Glucose regulates the intrinsic inflammatory response of the heart to surgically induced hypothermic ischemic arrest and reperfusion.

Authors:  Ahmed S Bux; Merry L Lindsey; Hernan G Vasquez; Heinrich Taegtmeyer; Romain Harmancey
Journal:  Physiol Genomics       Date:  2016-12-09       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.